Yao Lei, Pike Sandra E, Tosato Giovanna
Experimental Transplantation and Immunology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.
J Leukoc Biol. 2002 Jan;71(1):47-53.
Vasostatin, the 1-180 amino acids NH(2) domain of calreticulin, inhibits endothelial cell proliferation, angiogenesis, and tumor growth, but the mechanisms underlying these effects are unclear. We show that endothelial cells express the extracellular matrix protein laminin, including chains alpha 5 and gamma 1 and that vasostatin specifically binds to laminin. When added to endothelial cell cultures, vasostatin specifically inhibits endothelial cell attachment to laminin and by this mechanism, can reduce subsequent endothelial cell growth induced by basic fibroblast growth factor. As an angiogenesis inhibitor that specifically disrupts endothelial cell attachment to components of the extracellular matrix, vasostatin has a unique potential as a cancer therapeutic.
血管抑素是钙网蛋白的1 - 180个氨基酸的NH(2)结构域,可抑制内皮细胞增殖、血管生成和肿瘤生长,但其作用机制尚不清楚。我们发现内皮细胞表达细胞外基质蛋白层粘连蛋白,包括α5和γ1链,且血管抑素能特异性结合层粘连蛋白。将血管抑素添加到内皮细胞培养物中时,它能特异性抑制内皮细胞与层粘连蛋白的附着,通过这种机制,可减少碱性成纤维细胞生长因子诱导的后续内皮细胞生长。作为一种特异性破坏内皮细胞与细胞外基质成分附着的血管生成抑制剂,血管抑素作为癌症治疗药物具有独特的潜力。